-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Aridis Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2017 to 2021.
- Aridis Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2023 was 37.4M shares, a 111% increase year-over-year.
- Aridis Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 12.3M shares, a 34.1% increase from 2020.
- Aridis Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 9.17M shares.
- Aridis Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2018 was 3.15M shares, a 1791% increase from 2017.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)